The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

RecruitingOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Urothelial Carcinoma
Interventions
DIAGNOSTIC_TEST

IUrisure test

Postoperative patients are followed up every three months on average, and IUrisure test was performed at each follow-up visit.

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Wuhan Ammunition Life-tech Co., Ltd

INDUSTRY